Litcius/Paper detail

Enhanced Rim on MDCT of Colorectal Liver Metastases: Assessment of Ability to Predict Progression-Free Survival and Response to Bevacizumab-Based Chemotherapy

Jin Cheng, Meng Qiu, Yinli Zhang, Nan Hong, Danhua Shen, Jing Zhou, Yi Wang

2020American Journal of Roentgenology15 citationsDOI

Abstract

The presence of an enhanced rim on PVP MDCT is an independent predictor of survival and response to bevacizumab-based chemotherapy among patients with CRLM.

Topics & Concepts

MedicineBevacizumabColorectal cancerChemotherapyOncologyOverall survivalInternal medicineRadiologyMetastasisCancerColorectal Cancer Treatments and StudiesHepatocellular Carcinoma Treatment and PrognosisRadiomics and Machine Learning in Medical Imaging
Enhanced Rim on MDCT of Colorectal Liver Metastases: Assessment of Ability to Predict Progression-Free Survival and Response to Bevacizumab-Based Chemotherapy | Litcius